EP06.03. The Prognostic Impact of Postoperative EGFR Mutation Status in Lung Cancer Patients with Stage II - III - PDF(Slides)
Back to course
Pdf Summary
Asset Subtitle
Shota Nakamura
Meta Tag
Speaker Shota Nakamura
Topic Pathology & Biomarkers: Genetic Biomarkers
epidermal growth factor receptor mutation
lung adenocarcinoma
surgical resection
non-small cell lung cancer
disease-free survival
overall survival
adjuvant therapy
tyrosine kinase inhibitors
immune checkpoint inhibitors
cisplatin-based chemotherapy
Powered By